First Horizon Advisors, Inc. Dexcom Inc Transaction History

First Horizon Advisors, Inc.

$3.81 Billion
Q2 2025

A detailed history of First Horizon Advisors, Inc. transactions in Dexcom Inc stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 2,281 shares of DXCM stock, worth $132,799. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,281

Previous 1,582 44.18%

Holding current value

$132,799

Previous $108,000 84.26%

% of portfolio

0.01%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 05, 2025	BUY	$59.83 - $87.57 $41,821 - $61,211	699 Added 44.18%	2,281 $199,000
Q1 2025 Apr 28, 2025	BUY	$67.74 - $90.75 $21,676 - $29,040	320 Added 25.36%	1,582 $108,000
Q4 2024 Feb 03, 2025	SELL	$65.68 - $81.01 $19,309 - $23,816	-294 Reduced 18.89%	1,262 $98,000
Q3 2024 Nov 08, 2024	BUY	$64.0 - $116.06 $5,696 - $10,329	89 Added 6.07%	1,556 $104,000
Q2 2024 Jul 19, 2024	BUY	$110.31 - $140.45 $51,294 - $65,309	465 Added 46.41%	1,467 $166,000
Q1 2024 Apr 26, 2024	BUY	$114.22 - $140.1 $6,282 - $7,705	55 Added 5.81%	1,002 $138,000
Q4 2023 Feb 06, 2024	BUY	$75.49 - $124.16 $3,095 - $5,090	41 Added 4.53%	947 $117,000
Q3 2023 Oct 27, 2023	BUY	$86.06 - $137.93 $3,958 - $6,344	46 Added 5.35%	906 $84,000
Q2 2023 Aug 03, 2023	SELL	$112.47 - $130.98 $5,623 - $6,548	-50 Reduced 5.49%	860 $110,000
Q1 2023 May 15, 2023	SELL	$104.0 - $122.92 $5,200 - $6,146	-50 Reduced 5.21%	910 $105,000
Q4 2022 Feb 10, 2023	BUY	$84.98 - $122.67 $7,308 - $10,549	86 Added 9.84%	960 $108,000
Q3 2022 Nov 09, 2022	BUY	$76.35 - $94.18 $1,756 - $2,166	23 Added 2.7%	874 $69,000
Q2 2022 Aug 02, 2022	BUY	$67.99 - $132.89 $52,896 - $103,388	778 Added 1065.75%	851 $63,000
Q1 2022 May 10, 2022	SELL	$94.08 - $130.2 $13,641 - $18,879	-145 Reduced 66.51%	73 $37,000
Q4 2021 Feb 09, 2022	SELL	$129.87 - $162.82 $2,467 - $3,093	-19 Reduced 8.02%	218 $29,000
Q3 2021 Nov 15, 2021	SELL	$106.71 - $143.18 $736,725 - $988,514	-6,904 Reduced 96.68%	237 $32,000
Q3 2021 Nov 09, 2021	BUY	$106.71 - $143.18 $739,927 - $992,810	6,934 Added 3349.76%	7,141 $976,000
Q2 2021 Aug 09, 2021	BUY	$80.99 - $107.93 $3,725 - $4,964	46 Added 28.57%	207 $22,000
Q1 2021 May 11, 2021	BUY	$84.79 - $104.74 $13,651 - $16,863	161 New	161 $14,000
Q4 2020 Feb 11, 2021	SELL	$78.0 - $104.5 $858 - $1,149	-11 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$95.51 - $112.95 $477 - $564	-5 Reduced 31.25%	11 $1,000
Q2 2020 Jul 31, 2020	SELL	$62.68 - $105.34 $501 - $842	-8 Reduced 33.33%	16 $1,000
Q1 2020 May 05, 2020	BUY	$47.79 - $75.63 $1,146 - $1,815	24 New	24 $1,000
Q4 2017 Jan 25, 2018	SELL	$11.12 - $15.38 $3,113 - $4,306	-280 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	280	280 $0

Others Institutions Holding DXCM

# of Institutions

1,106

Shares Held

366M

Call Options Held

5.36M

Put Options Held

5.18M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $22.5B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Horizon Advisors, Inc. with notifications on news.

Account

First Horizon Advisors, Inc. Dexcom Inc Transaction History